{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:17:40Z","timestamp":1787894260802,"version":"build-2784847793"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Patients with severe aplastic anemia (SAA) proceeding to allogeneic hematopoietic cell transplantation (HCT) require reliable central venous access, yet the procedural evidence base was generated at platelet counts of roughly 10\u201350\u202f\u00d7\u202f10\n                      <jats:sup>9<\/jats:sup>\n                      \/L and does not extend to the extreme thrombocytopenia of marrow failure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>\n                      A 56-year-old woman with SAA, neutropenia, fungal maxillary sinusitis, scattered ecchymoses, and no active spontaneous bleeding required urgent multi-lumen access before conditioning. Her admission platelet count was 1\u202f\u00d7\u202f10\n                      <jats:sup>9<\/jats:sup>\n                      \/L, and after one 200-mL apheresis platelet transfusion the count measured approximately 14\u202fh later was 2\u202f\u00d7\u202f10\n                      <jats:sup>9<\/jats:sup>\n                      \/L, a poor sustained increment. Because that sample fell outside any standardized post-transfusion interval, a corrected count increment could not be calculated and refractoriness could not be established; HLA and HPA antibody testing was not available within the procedural window.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention and outcomes<\/jats:title>\n                    <jats:p>\n                      After multidisciplinary review, a second 200-mL apheresis platelet transfusion was given and a 5-Fr dual-lumen power-injectable PICC was inserted immediately afterward through the right basilic vein under ultrasound guidance. Insertion followed the transfusion without an interval, so the last recorded count of 2\u202f\u00d7\u202f10\n                      <jats:sup>9<\/jats:sup>\n                      \/L precedes the second unit and the value at venipuncture was not remeasured. The catheter-to-vein ratio, measured from the stored procedural images, was approximately 32%. Access was achieved on the first puncture and the tip confirmed in the lower third of the superior vena cava. World Health Organization grade 1 puncture-site oozing stopped after 10\u202fmin of compression. No bleeding of grade 2 or higher, transfusion reaction, occlusion, migration, catheter-related bloodstream infection, or clinically evident catheter-related thrombosis was documented over 63 catheter-days or at 3-month follow-up. Routine thrombosis-screening ultrasound was not performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This report documents how a coordinated risk-control pathway combining necessity assessment, platelet support, a compressible access site, first-pass ultrasound-guided insertion, and interval-specific surveillance was applied when transplantation could not be deferred, and it specifies the measurements that future prospective series should capture. A single case cannot establish the safety of PICC placement at extremely low platelet counts or define a platelet threshold, particularly because the count at the time of insertion was not remeasured.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1915465","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:30:32Z","timestamp":1787891432000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Urgent ultrasound-guided dual-lumen PICC placement after platelet transfusion in severe aplastic anemia with extreme thrombocytopenia"],"prefix":"10.3389","volume":"13","author":[{"given":"Yeyan","family":"He","sequence":"first","affiliation":[{"name":"Medical Center of Hematology, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Li","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Feng","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Chen","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"bloodadvances.2025019051","DOI":"10.1182\/bloodadvances.2025019051","article-title":"American Society of Hematology 2026 guidelines for the diagnosis and management of severe and very severe acquired aplastic anemia","author":"Scheinberg","year":"2026","journal-title":"Blood Adv"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jtct.2024.09.017","article-title":"Allogeneic hematopoietic cell transplantation for the treatment of severe aplastic anemia: evidence-based guidelines from the American Society for Transplantation and Cellular Therapy","volume":"30","author":"Iftikhar","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1182\/bloodadvances.2023011642","article-title":"Modified Delphi panel consensus recommendations for management of severe aplastic anemia","volume":"8","author":"Babushok","year":"2024","journal-title":"Blood Adv"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.2025.7529","article-title":"Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines","volume":"334","author":"Metcalf","year":"2025","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1056\/NEJMoa2214322","article-title":"Platelet transfusion before CVC placement in patients with thrombocytopenia","volume":"388","author":"van Baarle","year":"2023","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s00330-013-2778-1","article-title":"Peripherally inserted central catheter placement in cancer patients with profound thrombocytopaenia: a prospective analysis","volume":"23","author":"Potet","year":"2013","journal-title":"Eur Radiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00277-022-04891-y","article-title":"Lowering platelet count threshold to 10,000\/microL for peripherally inserted central catheter placement safely conserves blood products","volume":"101","author":"Amirahmadi","year":"2022","journal-title":"Ann Hematol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1007\/s00277-025-06717-z","article-title":"Safety and risk factors of PICC insertion in hematologic malignancy patients with thrombocytopenia: a retrospective study","volume":"104","author":"Zhang","year":"2025","journal-title":"Ann Hematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","article-title":"Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality","volume":"48","author":"Camitta","year":"1976","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/NAN.0000000000000532","article-title":"Infusion therapy standards of practice, 9th edition","volume":"47","author":"Nickel","year":"2024","journal-title":"J Infus Nurs"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.7326\/M15-0744","article-title":"The Michigan appropriateness guide for intravenous catheters: results from a multispecialty panel using the RAND\/UCLA appropriateness method","volume":"163","author":"Chopra","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","article-title":"Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00134-012-2597-x","article-title":"International evidence-based recommendations on ultrasound-guided vascular access","volume":"38","author":"Lamperti","year":"2012","journal-title":"Intensive Care Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1017\/ice.2022.87","article-title":"Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update","volume":"43","author":"Buetti","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00277-020-04286-x","article-title":"Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management and prevention by the infectious diseases working Party of the German Society of hematology and medical oncology","volume":"100","author":"B\u00f6ll","year":"2021","journal-title":"Ann Hematol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2450572","DOI":"10.1080\/16078454.2025.2450572","article-title":"Outcomes of peripherally inserted central catheter vs conventional central venous catheters in hematological cancer patients: a systematic review and meta-analysis","volume":"30","author":"Ge","year":"2025","journal-title":"Hematology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1752-1947-7-223","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"7","author":"Gagnier","year":"2013","journal-title":"J Med Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1915465\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:30:58Z","timestamp":1787891458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1915465\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":21,"alternative-id":["10.3389\/fmed.2026.1915465"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1915465","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"1915465"}}